Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNAI3 | P08754 | 1/20 | 0.57 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.57 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.57 |
| ▸ | PAOX | Q6QHF9 | 2/20 | 0.55 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.54 |
| ▸ | EPHX1 | P07099 | 6/20 | 0.54 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.53 |
| ▸ | RRM1 | P23921 | 1/20 | 0.51 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.51 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.51 |
| ▸ | CASP2 | P42575 | 1/20 | 0.48 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11286835 | 0.98 | GNAI3 (0.60) | GNAI3GNAO1GNAI1PAOXSLC6A5 | |
| SCHEMBL25252984 | 0.98 | GNAI3 (0.60) | GNAI3GNAO1GNAI1PAOXSLC6A5 | |
| Octadecylamine SCHEMBL910406 | 0.98 | GNAI3 (0.60) | GNAI3GNAO1GNAI1PAOXSLC6A5 | |
| SCHEMBL1479336 | 0.98 | GNAI3 (0.60) | GNAI3GNAO1GNAI1PAOXSLC6A5 | |
| Propylamine SCHEMBL28079902 | 0.92 | EPHX1 (0.59) | GNAI3GNAO1GNAI1PAOXSLC6A5 | |
| Butylamine SCHEMBL909929 | 0.89 | EPHX1 (0.48) | GNAI3GNAO1GNAI1PAOXSLC6A5 | |
| SCHEMBL176011 | 0.89 | — | — | |
| SCHEMBL1486485 | 0.89 | — | — | |
| Dectaflur SCHEMBL22558107 | 0.88 | SLC6A5 (0.73) | GNAI3GNAO1GNAI1SLC6A5 | |
| SCHEMBL2440729 | 0.87 | EPHX1 (0.70) | EPHX1CASP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10799443-B2 | Crosslinkable coating compositions formulated with dormant carbamate initiator | ELEMENTIS SPECIALTIES, INC. (US) | 2020-10-13 | — | — | US | claimed |
| US-20200214966-A1 | CROSSLINKABLE COATING COMPOSITIONS FORMULATED WITH DORMANT CARBAMATE INITIATOR | ELEMENTIS SPECIALTIES, INC. (US) | 2020-07-09 | — | — | US | claimed |
| US-12623999-B2 | Carbamate production method, carbamate ester production method, and urea derivative production method | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2026-05-12 | — | — | US | disclosed |
| US-12501540-B2 | Electronic device and manufacturing method thereof | FUJIFILM CORPORATION (JP) | 2025-12-16 | — | — | US | disclosed |
| US-12451440-B2 | Electronic device and manufacturing method thereof | FUJIFILM CORPORATION (JP) | 2025-10-21 | — | — | US | disclosed |
| US-12389549-B2 | Manufacturing method of electronic device | FUJIFILM CORPORATION (JP) | 2025-08-12 | — | — | US | disclosed |
| US-20250236954-A1 | MANUFACTURING METHOD OF CONDUCTIVE FILM AND MANUFACTURING METHOD OF ELECTROMAGNETIC WAVE SHIELDING BODY | FUJIFILM CORPORATION (JP) | 2025-07-24 | — | — | US | disclosed |
| US-20240425715-A1 | MANUFACTURING METHOD OF CONDUCTIVE LAYER | FUJIFILM CORPORATION (JP) | 2024-12-26 | — | — | US | disclosed |
| US-20240424817-A1 | MANUFACTURING METHOD OF CONDUCTOR, MANUFACTURING METHOD OF ELECTROMAGNETIC WAVE SHIELDING BODY, AND CONDUCTOR | FUJIFILM CORPORATION (JP) | 2024-12-26 | — | — | US | disclosed |
| US-20240414839-A1 | MANUFACTURING METHOD OF PRINTED CIRCUIT BOARD | FUJIFILM CORPORATION (JP) | 2024-12-12 | — | — | US | disclosed |
| US-12110408-B2 | Conductive laminate and manufacturing method of conductive laminate | FUJIFILM CORPORATION (JP) | 2024-10-08 | — | — | US | disclosed |
| US-10624833-B2 | Crosslinkable coating compositions formulated with dormant carbamate initiator | ELEMENTIS SPECIALTIES, INC. (US) | 2020-04-21 | — | — | US | disclosed |
| CN-110958913-A | Coating system | 海名斯精细化工公司 | 2020-04-03 | — | — | CN | disclosed |
| EP-3478299-A1 | CROSSLINKABLE COATING COMPOSITIONS FORMULATED WITH DORMANT CARBAMATE INITIATOR | Elementis Specialties, Inc. (US) | 2019-05-08 | — | — | EP | disclosed |
| US-20180355185-A1 | COATING SYSTEM | ELEMENTIS SPECIALTIES, INC. (US) | 2018-12-13 | — | — | US | disclosed |
| US-20180118967-A1 | Metal Nanoparticle Ink Compositions For Printed Electronic Device Applications | XEROX CORPORATION | 2018-05-03 | — | — | US | disclosed |
| EP-3315564-A1 | METAL NANOPARTICLE INK COMPOSITIONS FOR PRINTED ELECTRONIC DEVICE APPLICATIONS | Xerox Corporation (US) | 2018-05-02 | — | — | EP | disclosed |
| US-20180000720-A1 | CROSSLINKABLE COATING COMPOSITIONS FORMULATED WITH DORMANT CARBAMATE INITIATOR | ELEMENTIS SPECIALTIES, INC. (US) | 2018-01-04 | — | — | US | disclosed |
| WO-2018005077-A1 | CROSSLINKABLE COATING COMPOSITIONS FORMULATED WITH DORMANT CARBAMATE INITIATOR | ELEMENTIS SPECIALTIES, INC. (US) | 2018-01-04 | — | — | WO | disclosed |
| US-20090142482-A1 | Methods of Printing Conductive Silver Features | XEROX CORPORATION (US) | 2009-06-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200214966-A1 | CROSSLINKABLE COATING COMPOSITIONS FORMULATED WITH DORMANT CARBAMATE INITIATOR | ETF1, CECR2, H1-2 | GNAI3 3199/4885GNAO1 2619/4885GNAI1 2282/4885 |
| US-10799443-B2 | Crosslinkable coating compositions formulated with dormant carbamate initiator | ETF1, CECR2, H1-2 | GNAI3 3199/4885GNAO1 2619/4885GNAI1 2282/4885 |
| US-10624833-B2 | Crosslinkable coating compositions formulated with dormant carbamate initiator | ETF1, CECR2, H1-2 | GNAI3 3199/4885GNAO1 2619/4885GNAI1 2282/4885 |
| US-12623999-B2 | Carbamate production method, carbamate ester production method, and urea derivative production method | CPS1, CA2, CHRM2 | GNAI3 4040/4885GNAO1 1736/4885GNAI1 3179/4885 |
| US-20180000720-A1 | CROSSLINKABLE COATING COMPOSITIONS FORMULATED WITH DORMANT CARBAMATE INITIATOR | ETF1, CECR2, H1-2 | GNAI3 3199/4885GNAO1 2619/4885GNAI1 2282/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.